Private Trust Company’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,063
Closed -$44.6K 2334
2024
Q3
$44.6K Hold
1,063
﹤0.01% 1182
2024
Q2
$43.4K Hold
1,063
﹤0.01% 1165
2024
Q1
$44.1K Hold
1,063
﹤0.01% 1149
2023
Q4
$43K Hold
1,063
0.01% 1115
2023
Q3
$41.6K Hold
1,063
0.01% 1085
2023
Q2
$43.2K Hold
1,063
0.01% 1086
2023
Q1
$44.5K Hold
1,063
0.01% 1030
2022
Q4
$46K Hold
1,063
0.01% 981
2022
Q3
$41K Hold
1,063
0.01% 958
2022
Q2
$45K Buy
+1,063
New +$46.2K 0.01% 965

Other funds holding BME

Private Trust Company's BME Position: Q4 2024 in Review

Private Trust Company sold out of BlackRock Health Sciences Trust (BME) in Q4 2024, closing a stake of 1,063 shares — an estimated $44.6K sold.

Private Trust Company first reported a position in BME in Q2 2022 and held it in 10 quarters. The position peaked at $46K in Q4 2022. 73 funds tracked by Wall St. Rank hold BME as of Q4 2024.

  • Private Trust Company reported no remaining BlackRock Health Sciences Trust position as of Q4 2024 after selling out during the quarter.
  • Private Trust Company sold 1,063 BlackRock Health Sciences Trust shares in Q4 2024, an estimated $44.6K.
  • Private Trust Company first reported a position in BlackRock Health Sciences Trust in Q2 2022 and held it in 10 quarters.
  • Private Trust Company's BlackRock Health Sciences Trust position peaked at $46K in Q4 2022.
  • 73 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2024.

Based on Private Trust Company's 13F filing for Q4 2024, filed 5 Feb 2025.